New Delhi: On Friday, India’s National Pharmaceutical Pricing Authority announced a 10.7% increase in the Wholesale Price Index (WPI) for calendar year 2021 over the same time in 2020.
This implies that effective April 1, the prices of roughly 800 scheduled medicines on the National List of Essential Medicines, which are needed to treat the majority of common disorders, will increase by 10.7%.
“Based on the WPI data provided by the office of the Economic Advisor, Ministry of Commerce and Industry, the annual change in WPI works out as 10.76607% during the calendar year 2021 over the corresponding period in 2020,” the NPPA notice said.
Medicines for fever, infections, heart illness, high blood pressure, skin problems, and anaemia will now be more expensive. Paracetamol, Phenobarbitone, Phenytoin Sodium, Azithromycin, Ciprofloxacin Hydrochloride, and Metronidazole are examples of such medications.
“This is brought to the notice of all concerned for further action as per the provisions of Drugs (Price Control) Order, 2013,” it added.
As an independent media platform, we do not take advertisements from governments and corporate houses. It is you, our readers, who have supported us on our journey to do honest and unbiased journalism. Please contribute, so that we can continue to do the same in future.
